MAPKAPK5 (MAPK activated protein kinase 5)

2003-11-01  

Identity

HGNC
LOCATION
12q24.12
LOCUSID
ALIAS
MAPKAP-K5,MK-5,MK5,PRAK
FUSION GENES

Other Information

Locus ID:

NCBI: 8550
MIM: 606723
HGNC: 6889
Ensembl: ENSG00000089022

Variants:

dbSNP: 8550
ClinVar: 8550
TCGA: ENSG00000089022
COSMIC: MAPKAPK5

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000089022ENST00000547305R4GN93
ENSG00000089022ENST00000549875R4GN33
ENSG00000089022ENST00000550735Q8IW41
ENSG00000089022ENST00000551404Q8IW41
ENSG00000089022ENST00000553053F8VRP2

Expression (GTEx)

0
5
10
15
20

Pathways

PathwaySourceExternal ID
MAPK signaling pathwayKEGGko04010
MAPK signaling pathwayKEGGhsa04010
Signal TransductionREACTOMER-HSA-162582
MAPK family signaling cascadesREACTOMER-HSA-5683057
MAPK6/MAPK4 signalingREACTOMER-HSA-5687128
Gene ExpressionREACTOMER-HSA-74160
Generic Transcription PathwayREACTOMER-HSA-212436
Transcriptional Regulation by TP53REACTOMER-HSA-3700989
Cellular responses to stressREACTOMER-HSA-2262752
Cellular SenescenceREACTOMER-HSA-2559583
Oxidative Stress Induced SenescenceREACTOMER-HSA-2559580
Regulation of TP53 ActivityREACTOMER-HSA-5633007
Regulation of TP53 Activity through PhosphorylationREACTOMER-HSA-6804756

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
365814492023Consolidating the association of biallelic MAPKAPK5 pathogenic variants with a distinct syndromic neurodevelopmental disorder.1
365814492023Consolidating the association of biallelic MAPKAPK5 pathogenic variants with a distinct syndromic neurodevelopmental disorder.1
350646192022TLK1-mediated MK5-S354 phosphorylation drives prostate cancer cell motility and may signify distinct pathologies.5
354687212022MAPKAPK5-AS1 drives the progression of hepatocellular carcinoma via regulating miR-429/ZEB1 axis.4
355752172022Expanding the novel MAPKAPK5-related developmental disorder's genotype-phenotype correlation: Patient report and 19 months of follow-up.2
358447892022The TTYH3/MK5 Positive Feedback Loop regulates Tumor Progression via GSK3-β/β-catenin signaling in HCC.4
350646192022TLK1-mediated MK5-S354 phosphorylation drives prostate cancer cell motility and may signify distinct pathologies.5
354687212022MAPKAPK5-AS1 drives the progression of hepatocellular carcinoma via regulating miR-429/ZEB1 axis.4
355752172022Expanding the novel MAPKAPK5-related developmental disorder's genotype-phenotype correlation: Patient report and 19 months of follow-up.2
358447892022The TTYH3/MK5 Positive Feedback Loop regulates Tumor Progression via GSK3-β/β-catenin signaling in HCC.4
334420262021Biallelic truncating variants in MAPKAPK5 cause a new developmental disorder involving neurological, cardiac, and facial anomalies combined with synpolydactyly.3
334420262021Biallelic truncating variants in MAPKAPK5 cause a new developmental disorder involving neurological, cardiac, and facial anomalies combined with synpolydactyly.3
315782002019MK5 Regulates YAP Stability and Is a Molecular Target in YAP-Driven Cancers.21
315782002019MK5 Regulates YAP Stability and Is a Molecular Target in YAP-Driven Cancers.21
289411482017MK5: A novel regulator of cardiac fibroblast function?9

Citation

Dessen P

MAPKAPK5 (MAPK activated protein kinase 5)

Atlas Genet Cytogenet Oncol Haematol. 2003-11-01

Online version: http://atlasgeneticsoncology.org/gene/41296/mapkapk5-(mapk-activated-protein-kinase-5)